Literature DB >> 3279057

Localization of protease nexin-1 on the fibroblast extracellular matrix.

D H Farrell1, S L Wagner, R H Yuan, D D Cunningham.   

Abstract

Protease nexin-1 (PN-1) is a protease inhibitor that is secreted by fibroblasts and several other cultured cells. PN-1 forms complexes with certain serine proteases in the extracellular environment including thrombin, urokinase, and plasmin. The complexes then bind to the cells and are rapidly internalized and degraded. This report demonstrates that PN-1 is present on the surface of fibroblasts, bound to the extracellular matrix. Immunofluorescent studies showed that PN-1 colocalized with fibronectin on both intact cells and in preparations of extracellular matrix made from these cells. In contrast, PN-1 did not colocalize with the epidermal growth factor receptor, a plasma membrane marker. An enzyme-lined immunosorbent assay was developed which showed that the extracellular matrix contained at least 60-80% of the cellular immunoreactive PN-1. Extraction of the matrix with 2 M NaCl removed PN-1 in a form which reacted with 125I-thrombin to form complexes which were immunoprecipitated by anti-PN-1 IgG and were of identical size as complexes made from soluble PN-1 and 125I-thrombin. These data indicate that in addition to its role as a soluble protease inhibitor, PN-1 is also a component of the extracellular matrix and might control its proteolysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279057     DOI: 10.1002/jcp.1041340203

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells.

Authors:  G David; B van der Schueren; P Marynen; J J Cassiman; H van den Berghe
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

2.  Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.

Authors:  S L Wagner; J W Geddes; C W Cotman; A L Lau; D Gurwitz; P J Isackson; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases.

Authors:  B H Choi; M Suzuki; T Kim; S L Wagner; D D Cunningham
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Modulation of fibrinolysis by ionizing radiation.

Authors:  J S Rao; A Rayford; M Yamamoto; K K Ang; P Tofilon; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 5.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

6.  Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death.

Authors:  Hisatsugu Koshimizu; Niamh X Cawley; Alfred L Yergy; Y Peng Loh
Journal:  J Mol Neurosci       Date:  2011-05-03       Impact factor: 3.444

7.  Comprehensive profiling of cartilage extracellular matrix formation and maturation using sequential extraction and label-free quantitative proteomics.

Authors:  Richard Wilson; Anders F Diseberg; Lavinia Gordon; Snezana Zivkovic; Liliana Tatarczuch; Eleanor J Mackie; Jeffrey J Gorman; John F Bateman
Journal:  Mol Cell Proteomics       Date:  2010-02-26       Impact factor: 5.911

8.  Novel ELISA for the specific detection of protease NEXIN-1 in human biological samples.

Authors:  Laurence Venisse; Déborah François; Célina Madjène; Els Brouwers; Emmanuelle de Raucourt; Yacine Boulaftali; Paul Declerck; Véronique Arocas; Marie-Christine Bouton
Journal:  Res Pract Thromb Haemost       Date:  2022-07-19

9.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.

Authors:  Sébastien Bergeron; Etienne Lemieux; Véronique Durand; Sébastien Cagnol; Julie C Carrier; Jacques G Lussier; Marie-Josée Boucher; Nathalie Rivard
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

Review 10.  Tumor invasion, proteolysis, and angiogenesis.

Authors:  U P Thorgeirsson; C K Lindsay; D W Cottam; D E Gomez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.